Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Pathology
    August 2017
  1. CHOI JS, Kim KH, Oh E, Shin YK, et al
    Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
    Pathology. 2017 Aug 14. pii: S0031-3025(17)30144.
    >> Share

    April 2017
  2. KEENEY MG, Couch FJ, Visscher DW, Lindor NM, et al
    Non-BRCA familial breast cancer: review of reported pathology and molecular findings.
    Pathology. 2017 Apr 24. pii: S0031-3025(17)30080.
    >> Share

  3. JING N, Fang C, Williams DS
    Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.
    Pathology. 2017 Apr 24. pii: S0031-3025(16)40481.
    >> Share

  4. ARMES JE, Galbraith C, Gray J, Taylor K, et al
    The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.
    Pathology. 2017;49:267-270.
    >> Share

    February 2017
  5. TOROUS VF, Schnitt SJ, Collins LC
    Benign breast lesions that mimic malignancy.
    Pathology. 2017;49:181-196.
    >> Share

  6. DAHLSTROM JE, Rakha EA, Lakhani SR, Schnitt SJ, et al
    Current topics in breast pathology: expert perspectives.
    Pathology. 2017;49:109-110.
    >> Share

  7. GINTER PS, McIntire PJ, Shin SJ
    Vascular tumours of the breast: a comprehensive review with focus on diagnostic challenges encountered in the core biopsy setting.
    Pathology. 2017;49:197-214.
    >> Share

    January 2017
  8. SIMMONS A, Burrage PM, Nicolau DV Jr, Lakhani SR, et al
    Environmental factors in breast cancer invasion: a mathematical modelling review.
    Pathology. 2017 Jan 9. pii: S0031-3025(16)40507.
    >> Share

  9. PENAULT-LLORCA F, Radosevic-Robin N
    Ki67 assessment in breast cancer: an update.
    Pathology. 2017 Jan 5. pii: S0031-3025(16)40573.
    >> Share

    December 2016
  10. LUEN SJ, Savas P, Fox SB, Salgado R, et al
    Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Pathology. 2016 Dec 31. pii: S0031-3025(16)40413.
    >> Share

  11. MCCUAIG R, Wu F, Dunn J, Rao S, et al
    The biological and clinical significance of stromal-epithelial interactions in breast cancer.
    Pathology. 2016 Dec 29. pii: S0031-3025(16)40368.
    >> Share

  12. RAKHA EA, Green AR
    Molecular classification of breast cancer: what the pathologist needs to know.
    Pathology. 2016 Dec 28. pii: S0031-3025(16)40365.
    >> Share

  13. ROSS JS, Gay LM
    Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.
    Pathology. 2016 Dec 26. pii: S0031-3025(16)40362.
    >> Share

  14. ALI R, Rakha EA, Madhusudan S, Bryant HE, et al
    DNA damage repair in breast cancer and its therapeutic implications.
    Pathology. 2016 Dec 26. pii: S0031-3025(16)40417.
    >> Share

  15. FICIAL M, Parisi A, Remo A, Vasori S, et al
    Usefulness of breast cytology after lipofilling.
    Pathology. 2016;48:746-747.
    >> Share

    August 2016
  16. MOREY AL, Brown B, Farshid G, Fox SB, et al
    Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.
    Pathology. 2016 Aug 23. pii: S0031-3025(16)38281.
    >> Share

    February 2016
  17. KEEMAN H, Harris GC
    An audit of frontline (F)ISH testing outside the Australian setting on HER2 positivity rates in breast cancer and the impact of the 2013 ASCO guidelines.
    Pathology. 2016;48 Suppl 1:S61.
    >> Share

  18. SHUI R, Yu B, Bi R, Yang F, et al
    An interobserver reproducibility analysis of ki67 visual assessment in breast cancer.
    Pathology. 2016;48 Suppl 1:S155-S156.
    >> Share

  19. BECKERS RK, Selinger C, Vilain R, Madore J, et al
    PDl1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
    Pathology. 2016;48 Suppl 1:S146-S147.
    >> Share

  20. MUSTOKOWENI S
    The profile of immunohistochemistry test for breast cancer in Dr Soetomo Hospital Surabaya, Indonesia.
    Pathology. 2016;48 Suppl 1:S145.
    >> Share

  21. GWAK JM, Kim HJ, Kim EJ, Park SY, et al
    Clinicopathologic significance of MIR-221/222 expression in breast cancer.
    Pathology. 2016;48 Suppl 1:S128.
    >> Share

  22. DIN TA, Seeni A, Yusoff MS, Shamsuddin S, et al
    PF4-Induced apoptosis in breast cancer in vivo study: The role of the caspases family.
    Pathology. 2016;48 Suppl 1:S122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016